Alagille Syndrome and a JAG1 Mutation: 41 Cases of Experience at a Single Center

Overview

Journal Korean J Pediatr

Specialty Pediatrics

Date 2015 Nov 18

PMID 26576184

Citations 9

Authors

Kyung Jin Ahn

Ja Kyoung Yoon

Gi Beom Kim

Bo Sang Kwon

Jung Min Go

Jin Su Moon

Eun Jung Bae

Chung Il Noh

Affiliations

Soon will be listed here.

Abstract

Purpose: Alagille syndrome is a complex hereditary disorder that is associated with cardiac, hepatic, skeletal, ocular, and facial abnormalities. Mutations in the Notch signaling pathway, such as in JAG1 and NOTCH2, play a key role in embryonic development. A cardiac or hepatic presentation is a critical factor for determining the prognosis.

Methods: We conducted a retrospective study of 41 patients with Alagille syndrome or a JAG1 mutation between 1983 and 2013.

Results: The first presentations were jaundice, murmur, cyanosis, and small bowel obstruction at a median age of 1.0 months (range, 0-24 months). The JAG1 mutation was found in 27 of the 28 genetically-tested patients. Cardiovascular anomalies were identified in 36 patients, chronic cholestasis was identified in 34, and liver transplantation was performed in 9. There was no significant correlation between the severity of the liver and cardiac diseases. The most common cardiovascular anomaly was peripheral pulmonary stenosis (83.3%), with 13 patients having significant hemodynamic derangement and 12 undergoing surgical repair. A total bilirubin level of >15 mg/dL with a complex surgical procedure increased the surgical mortality (P=0.022). Eight patients died after a median period of 2.67 years (range, 0.33-15 years). The groups with fetal presentation and with combined severe liver and heart disease had the poorest survival (P<0.001).

Conclusion: The group with combined severe liver and heart disease had the poorest survival, and a multidisciplinary approach is necessary to improve the outcome.

Citing Articles

The burden of Alagille syndrome: uncovering the potential of emerging therapeutics - a comprehensive systematic literature review.

Bufler P, Howard R, Quadrado L, Lacey G, Terner-Rosenthal J, Goldstein A J Comp Eff Res. 2025; 14(2):e240188.

PMID: 39807752 PMC: 11773862. DOI: 10.57264/cer-2024-0188.

Parachute Mitral Valve and Mid-Aortic Syndrome - Unusual Associations of Alagille Syndrome.

Bhagia G, Hussain N, Arty F, Bansal P, Biederman R Eur J Case Rep Intern Med. 2024; 11(6):004545.

PMID: 38846669 PMC: 11152214. DOI: 10.12890/2024_004545.

Pulmonary artery pathologies in Alagille syndrome: a meta-analysis.

Yuan S Postepy Kardiol Interwencyjnej. 2022; 18(2):111-117.

PMID: 36051836 PMC: 9421510. DOI: 10.5114/aic.2022.118526.

Genome-Wide Interaction Study of Late-Onset Asthma With Seven Environmental Factors Using a Structured Linear Mixed Model in Europeans.

Baek E, Jung H, Ha T, Kim D, Lim J, Kim H Front Genet. 2022; 13:765502.

PMID: 35432474 PMC: 9005993. DOI: 10.3389/fgene.2022.765502.

Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome.

Palma M, Igelman A, Ku C, Burr A, You J, Place E Invest Ophthalmol Vis Sci. 2021; 62(7):27.

PMID: 34185059 PMC: 8254011. DOI: 10.1167/iovs.62.7.27.

References

Lacour-Gayet F, Clarke D, Jacobs J, Comas J, Daebritz S, Daenen W . The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg. 2004; 25(6):911-24. DOI: 10.1016/j.ejcts.2004.03.027. View

McDaniell R, Warthen D, Sanchez-Lara P, Pai A, Krantz I, Piccoli D . NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet. 2006; 79(1):169-73. PMC: 1474136. DOI: 10.1086/505332. View

Guegan K, Stals K, Day M, Turnpenny P, Ellard S . JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome. Clin Genet. 2011; 82(1):33-40. DOI: 10.1111/j.1399-0004.2011.01749.x. View

Kamath B, Bason L, Piccoli D, Krantz I, Spinner N . Consequences of JAG1 mutations. J Med Genet. 2003; 40(12):891-5. PMC: 1735339. DOI: 10.1136/jmg.40.12.891. View

Srivastava A, Goel D, Bolia R, Poddar U, Yachha S . Alagille syndrome: experience of a tertiary care center in North India. Indian J Gastroenterol. 2013; 33(1):59-62. DOI: 10.1007/s12664-013-0392-4. View

Turnpenny P, Ellard S . Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2011; 20(3):251-7. PMC: 3283172. DOI: 10.1038/ejhg.2011.181. View

Penton A, Leonard L, Spinner N . Notch signaling in human development and disease. Semin Cell Dev Biol. 2012; 23(4):450-7. PMC: 3638987. DOI: 10.1016/j.semcdb.2012.01.010. View

Lin H, Hoang P, Hutchinson A, Chao G, Gerfen J, Loomes K . Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features. Am J Med Genet A. 2012; 158A(5):1005-13. PMC: 3331947. DOI: 10.1002/ajmg.a.35255. View

Watson G, Miller V . Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child. 1973; 48(6):459-66. PMC: 1648450. DOI: 10.1136/adc.48.6.459. View

10.

Kamath B, Spinner N, Emerick K, Chudley A, Booth C, Piccoli D . Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004; 109(11):1354-8. DOI: 10.1161/01.CIR.0000121361.01862.A4. View

11.

Alagille D, Odievre M, Gautier M, Dommergues J . Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr. 1975; 86(1):63-71. DOI: 10.1016/s0022-3476(75)80706-2. View

12.

Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues J . Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr. 1987; 110(2):195-200. DOI: 10.1016/s0022-3476(87)80153-1. View

13.

Emerick K, Rand E, Goldmuntz E, Krantz I, Spinner N, Piccoli D . Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999; 29(3):822-9. DOI: 10.1002/hep.510290331. View

14.

Vajro P, Ferrante L, Paolella G . Alagille syndrome: an overview. Clin Res Hepatol Gastroenterol. 2012; 36(3):275-7. DOI: 10.1016/j.clinre.2012.03.019. View

15.

Warthen D, Moore E, Kamath B, Morrissette J, Sanchez-Lara P, Sanchez P . Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat. 2006; 27(5):436-43. DOI: 10.1002/humu.20310. View

16.

Li L, Krantz I, Deng Y, Genin A, Banta A, Collins C . Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997; 16(3):243-51. DOI: 10.1038/ng0797-243. View

17.

Spinner N, Colliton R, Crosnier C, Krantz I, Hadchouel M . Jagged1 mutations in alagille syndrome. Hum Mutat. 2001; 17(1):18-33. DOI: 10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T. View

18.

Jurkiewicz D, Gliwicz D, Ciara E, Gerfen J, Pelc M, Piekutowska-Abramczuk D . Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome. J Appl Genet. 2014; 55(3):329-36. PMC: 4102774. DOI: 10.1007/s13353-014-0212-2. View

19.

Oda T, Elkahloun A, Pike B, Okajima K, Krantz I, Genin A . Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997; 16(3):235-42. DOI: 10.1038/ng0797-235. View

20.

Lykavieris P, Hadchouel M, Chardot C, Bernard O . Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut. 2001; 49(3):431-5. PMC: 1728437. DOI: 10.1136/gut.49.3.431. View